(“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical ...

1 Revive is targeting nerve agent exposure as its initial indication for its medical countermeasures program. Nerve agents are chemicals that affect the nervous system. Nerve agents are highly ...

Revive Health, a leading telehealth provider headquartered in Perrysburg, Ohio, is proud to announce its rebranding to Rixa Health, a name that embodies the company's unique vision for ...

TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...

1 Revive is targeting nerve agent exposure as its initial indication for its medical countermeasures program ... Inc. , a leading global provider of technology and data, announced today that Warren ...

TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive” or the "Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...

1 The Company will be focusing on the following programs with Bucillamine: Medical Countermeasures Revive is targeting nerve agent exposure as its initial indication for its medical ...

03, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd ... and development of therapeutics for infectious diseases and medical countermeasures, announced today an update on its research ...